Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy-Reference-Cited by-同舟云学术

Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy

Published:2017-10-31 Issue:1 Volume:7 Page:e1376156
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Yan Xiang¹²,Wang Li¹,Zhang Ran¹,Pu Xingxiang¹,Wu Shuhong¹,Yu Lili¹,Meraz Ismail M.¹,Zhang Xiaoshan¹,Wang Jacqueline F.¹,Gibbons Don L.³,Mehran Reza J.¹,Swisher Stephen G.¹,Roth Jack A.¹,Fang Bingliang¹

Affiliation:

1. Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China

3. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1376156

Reference44 articles.

1. Cancer statistics, 2017

2. Global cancer statistics, 2012

3. Predictive biomarkers in precision medicine and drug development against lung cancer

4. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

5. Cancer treatment and survivorship statistics, 2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic viruses in lung cancer treatment: a review article;Immunotherapy;2024-02

2. Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer;Scientific Reports;2023-04-12

3. Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application;Frontiers in Oncology;2023-02-21

4. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities;Journal of Cellular Physiology;2021-09-08

5. Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy;Scientific Reports;2021-07-19